Dose selection in phase I studies: Why we should always go for the most effective

Ian E. Haines

doi:10.1200/JCO.2008.17.6719

Dose selection in phase I studies: Why we should always go for the most effective

Ian E. Haines

Medicine Alfred Hospital

Research output: Contribution to journal › Letter › Other › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	3650-3652
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	26
Issue number	21
DOIs	https://doi.org/10.1200/JCO.2008.17.6719
Publication status	Published - 15 Sept 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2008.17.6719

Cite this

@article{d383400c38e1453bb6584c8acd310117,

title = "Dose selection in phase I studies: Why we should always go for the most effective",

author = "Haines, {Ian E.}",

year = "2008",

month = sep,

day = "15",

doi = "10.1200/JCO.2008.17.6719",

language = "English",

volume = "26",

pages = "3650--3652",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "21",

}

TY - JOUR

T1 - Dose selection in phase I studies

T2 - Why we should always go for the most effective

AU - Haines, Ian E.

PY - 2008/9/15

Y1 - 2008/9/15

UR - http://www.scopus.com/inward/record.url?scp=49049122081&partnerID=8YFLogxK

U2 - 10.1200/JCO.2008.17.6719

DO - 10.1200/JCO.2008.17.6719

M3 - Letter

C2 - 18640947

AN - SCOPUS:49049122081

SN - 0732-183X

VL - 26

SP - 3650

EP - 3652

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 21

ER -

Dose selection in phase I studies: Why we should always go for the most effective

UN SDGs

Access to Document

Other files and links

Cite this